XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Inventory - Narrative (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
 [1]
Inventory [Line Items]    
Inventories - current $ 70,442 $ 62,972
Inventories-noncurrent 297,974 $ 206,965
Inventory incurred prior to FDA approval $ 32,300  
Minimum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 7 months  
Maximum    
Inventory [Line Items]    
Period of lower average per unit cost of materials (in months) 27 months  
[1] The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date.